The fight against cancer becomes a losing battle for more men than women, according to health study statistics. Thus, it’s close to 40% of US adults who will receive bad news after completing a cancer examination. More so, there are those aware of others or loved ones discovering cancer symptoms through accurate screenings. Since 2014 — The National Cancer Institute is estimating a figure more than 14 million American citizens with cancer to increase above the 19 mark during 2024.
Fortunately, Tempus CEO, Eric Lefkofsky joins the fight against the disease by spearheading the effort to identify high-risk disease patients. With data-enabled medicine, medical directors will improve the examined recipient’s result by lessening the risk. When considering the use of traditional software, Tempus has advanced in prognosis descriptions. Those with the disease can now have hope in knowing about the survival chances and seriousness of their cancer.
Lefkofsky derived to recognize how lacking the cancer treatment was in the use of its produced technology. In addition, his wife’s cancer diagnosis of the breast was his close-up experience. Further, during his wife’s cancer treatment, Eric noticed the real problem was with the digital technology and collected data. Even so, he noted much-collected information was available on patients and their procedures. Also, he discovered how the outdated technology in compiling the data collection was ineffective.
Tempus has come up with a platform for delivering cancer care to patients by better analyzing a candidate’s molecular and clinical information. At first, the only setback was the affordability of accessing the medical data from the analytical software results. Further, the company figured out a way to collect and store important information from the patient’s treatment. The technology would transform the doctors’ progress notes to organized data, which would improve moving cancer prescriptions and care.
Founder of Groupon Eric Lefkofsky is one of Chicago’s most inspiring individuals within the technology area. As a philanthropist, he has provided significant donations to cancer research and to the cause of fighting against cancer. So, he’s currently behind the onset with an intelligent approach to finding a cure for cancer.
Both Lefkofsky and his wife Liz are contributing to advance the community life through the Lefkofsky Family Foundation, which was set up 2006 by Eric Lefkofsky. The charitable institution has been the means of promoting impacting enterprises.